|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,466.40 INR | -0.54% |
|
+3.63% | -2.97% |
| 07-28 | Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus | CI |
| 07-24 | Jefferies Adjusts Cipla's Price Target to INR1,170 From INR1,120, Keeps at Underperform | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 28.62x | 3.17x | 3.92x | 3.5x | 18.11x | 23.19x | 0.87% | 12.43B | ||
| 36.47x | 5.11x | 2.58x | 6.89x | 23.82x | 28.8x | 0.8% | 49.85B | ||
| 18.94x | 1.86x | -1.67x | 2.15x | 10.15x | 13.14x | 1.26% | 36.89B | ||
| 26.61x | 3.65x | -1.69x | 3.93x | 15.99x | 21.89x | 0.59% | 11.69B | ||
| 19.22x | 3.28x | 5.67x | 3.36x | 12.07x | 14.43x | 3.46% | 9.04B | ||
| 16.5x | 1.32x | 9.76x | 2.14x | 7.19x | 9.83x | 3.14% | 7.15B | ||
| 8.17x | 1.41x | 0.65x | 1.91x | 5.01x | 6.06x | 5.3% | 6.7B | ||
| 34.33x | 6.07x | 0.44x | 3.91x | 16.64x | 18.38x | 0.23% | 6.66B | ||
| 40.51x | 9.31x | 2.89x | 7.76x | 28.77x | 32.13x | 0.98% | 4.43B | ||
| 16.74x | 2.72x | 0.73x | 2.7x | 12.58x | 12.15x | 3.19% | 4.21B | ||
| 15.21x | 0.73x | -0.03x | 2.09x | 8.95x | 11.36x | 1.79% | 3.92B | ||
| 13.08x | - | 3.25x | 10.61x | 9.85x | 10.09x | - | 2.79B | ||
| 13.12x | 2.65x | 1.09x | 3.04x | 11.34x | 12.53x | 3.02% | 2.61B | ||
| 18.53x | 4.96x | 1.52x | 5.77x | 16.41x | 17.75x | 3.25% | 2.57B | ||
| 30.16x | - | -0.12x | - | - | - | - | 2.32B | ||
| 32.19x | 5.53x | 2.08x | - | - | - | - | 2.07B | ||
| Average | 23.03x | 3.70x | 1.94x | 4.27x | 14.06x | 16.55x | 2.15% | 10.33B | |
| Weighted average by Cap. | 26.15x | 3.63x | 1.57x | 4.37x | 16.12x | 19.72x | 1.49% |
- Stock Market
- Stocks
- CIPLA Stock
- Sector Cipla Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















